Comprehensive chemical analysis of Venenum Bufonis by using liquid chromatography/electrospray ionization tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 2, 2011, Pages 210-220

  Hu, Yongmei ^a   Yu, Zhiling ^a   Yang, Zhi Jun ^a   Zhu, Guoyuan ^a   Fong, Wangfun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Bufosteroids; LC ESI MS MS analysis; Semi quantification; Tentative characterization; Venenum Bufonis

Indexed keywords

12 HYDROXYL RESIBUFOGENIN; 19 HYDROXYL BUFALIN; 22,23 EPOXYCINOBUFOTALIN; 22,23 EPOXYRESIBUFOGENIN; AMPHIBIAN VENOM; ARENOBUFAGIN; ARGENTINOGENIN 3 ADIPATE ARGININE; BUFADIENOLIDE; BUFALIN; BUFALIN 3 ADIPATE ARGININE; BUFALIN 3 SEBACATE ARGININE; BUFALIN 3 SUCCINATE ARGININE; BUFOGENIN; BUFOTALIN; BUFOTALIN 3 GLUTARATE ARGININE; CHINESE DRUG; CINOBUFAGIN; DEACETYL CINOBUFAGIN; GAMABUFOTALIN; GAMABUFOTALIN 3 OXALATE; GAMABUFOTALIN 3 PELARGONATE ARGININE; GAMABUFOTALIN 3 SUBERATE ARGININE; HELLEBRIGENOL 9,11 ENE; MARINOBUFAGENIN; PHI BUFARENOGIN; SCILLARENINC 3 PIMELATE ARGININE; TELOCINOBUFAGIN; TELOCINOBUFAGIN 3 SUBERATE ARGININE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENENUM BUFONIS;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AMPHIBIAN VENOMS; ANIMALS; BUFANOLIDES; BUFONIDAE; CALIBRATION; CHROMATOGRAPHY, LIQUID; DRUGS, CHINESE HERBAL; MOLECULAR STRUCTURE; REFERENCE STANDARDS; SOLVENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL;

EID: 79960039453     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.05.014     Document Type: Article

References (29)

1. Shimada K., Fujii Y., Yamashita E., Niizaki Y., Sato Y., Nambara T. Studies on cardiotonic steroids from the skin of Japanese toad. Chem. Pharm. Bull. 1977, 25:714-730.
2. Fisher L.F., Fisher M. Cardiac-active principles. Steroids 1959, 727-730. Reinhold, New York.
3. Kopp B., Krenn L. Bufadienolides from animal and plant sources. Phytochemistry 1998, 48:1-29.
4. Takeda N. The metabolism of biogenic monoamines during embryogenesis and metamorphosis in two anuran species. Gen. Comp. Endocrinol. 1997, 106:361-373.
5. Ye M., Qu G.Q., Guo H.Z., Guo D.A. Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships. J. Steroid Biochem. Mol. Biol. 2004, 91:87-98.
6. Ye M., Han J., Tu G.Z., Guo D.A. Microbial hydroxylation of bufalin by unninghamella blakesleana and Mucor spinosus. J. Nat. Prod. 2005, 68:626-628.
7. Ye M., Qu G.Q., Guo H.Z., Guo D.A. Specific 12β-hydroxylation of cinobufagin by filamentous fungi. Appl. Environ. Microbiol. 2004, 70:3521-3527.
8. Furuya T., Kawaguchi K., Hirotani M. Biotransformation of digitoxigenin by cell suspension cultures of Strophanthus gratus. Phytochemistry 1988, 27:2129-2133.
9. He X.J., Tang J.S., Qiao A.M., Wang G.H., Jiang M.M., Liu R.H., Yao X.S. Cytotoxic biotransformed products from cinobufagin by Mucor spinosus and Aspergillus Niger. Steroids 2006, 71:392-402.
10. Chen K.K., Korarikova A. Pharmacology and toxicology of toad venom. J. Pharm. Sci. 1967, 56:1535-1541.
11. Yoshida S., Kamano Y., Sakai T. Studies on the surface anesthetic activity of bufadienolides isolated from Ch'an Su. Chem. Pharm. Bull. 1976, 24:1714-1717.
12. +-adenosine triphosphatase. J. Pharmacobio-Dyn. 1985, 8:1054-1059.
13. Yamada K., Hino K.I., Tomoyasu S., Honma Y. Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture. Leuk. Res. 1998, 22:589-595.
14. Qi F.H., Li A.Y., Zhao L., Xu H.L., Inagaki Y., Wang D.L., Cui X.Y., Gao B., Kokudo N., Nakata M., Tang W. Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. J. Ethnopharmacol. 2010, 128:654-661.
15. Zhang L.S., Nakaya K., Yoshida T., Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 1991, 178:686-693.
16. Zhang L.S., Nakaya K., Yoshida T., Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 1992, 52:4634-4641.
17. Nogawa T, Kamano Y., Yamashita A., Pettit G.R. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su. J. Nat. Prod. 2001, 64:1148-1152.
18. Hashimoto S., Jing Y.K., Kawazoe N., Masuda Y., Nakayo S., Yoshida T., Kuroiwa Y., Nakaya K. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk. Res. 1997, 21:875-883.
19. Yeh J.Y., Huang W.J., Kan S.F., Wang P.S. Effect of bufalin and cinobufalin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2003, 54:112-124.
20. Masuda Y., Kawazoe N., Nakayo S., Yoshida T., Kuroiwa Y., Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk. Res. 1995, 19:549-556.
21. Kamano Y., Yamashita A., Nogawa T., Morita H., Takeya K., Itokawa H., Segawa T., Yukita A., Saitou K., Katsuyama M., Pettit G.R. QSAR evaluation of the Chan' Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5. J. Med. Chem. 2002, 45:5440-5447.
22. Kamano Y., Kotake A., Hashima H., Inoue M., Morita H., Takeya K., Itokawa H., Nandachi N., Segawa T., Yukita A., Saitou K., Katsuyama M., Pettit G.R. Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorg. Med. Chem. 1998, 6:1103-1115.
23. Daly J.W., Myers C.W. Toxicity of panamanian poison frogs (dendrobates): some biological and chemical aspects. Science 1967, 156:970-973.
24. Kamano Y., Morita H., Takano R., Kotake A., Nogawa T., Hashima H., Takeya K., Itokawa H., Pettit G.R. Bufobutanoic acid and bufopyramide, two new indole alkaloids from the Chinese traditional drug Ch'an Su. Heterocycle 1999, 50:499-503.
25. Kawahara K., Mikage M. Studies on toad venom (3): effect of metals on the quality of toad venom torrefied on a metal plate. Yakugaku Zasshi 2002, 122:117-119.
26. McClean S., Robinson R.C., Shaw C., Smyth W.F. Characterisation and determination of indole alkaloids in frog-skin secretions by electrospray ionisation ion trap mass spectrometry. Rapid Commun. Mass Spectrom. 2002, 16:346-354.
27. Zhang P., Cui Z., Liu Y.S., Wang D., Liu N., Yoshikawa M. Quality evaluation of traditional chinese drug toad venom from different origins through a simultaneous determination of bufogenins and indole alkaloids by HPLC. Chem. Pharm. Bull. 2005, 53:1582-1586.
28. Xu W., Luo H., Zhang Y.P., Shan L., Li H.Y., Yang M., Liu R.H., Zhang W.D. Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometry. J. Chromatogr. B 2007, 859:157-163.
29. Ye M., Guo H., Guo H.Z., Han J., Guo D.A. Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine Chan Su by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detections. J. Chromatogr. B 2006, 838:86-95.